Cargando…

Long‐term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma

BACKGROUND: This study was performed to investigate whether long‐term monitoring of dynamic changes in plasma Epstein‐Barr virus (EBV) DNA could improve prognosis prediction of nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: About 1077 nonmetastatic NPC patients were recruited to retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wanxia, Chen, Jing, Liang, Bijun, Li, Zonghua, Li, Junzheng, Yuan, Xiaofei, Wu, Shuting, Zeng, Fangfang, Peng, Xinyu, Li, Yanfei, Lu, Juan, Zhao, Feipeng, Liu, Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897970/ https://www.ncbi.nlm.nih.gov/pubmed/33378109 http://dx.doi.org/10.1002/cam4.3669

Ejemplares similares

Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma
por: Li, Wanxia, et al.
Publicado: (2021)

Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study
por: Li, Wanxia, et al.
Publicado: (2022)

Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model
por: Liu, Wei, et al.
Publicado: (2021)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
por: Wakae, Kousho, et al.
Publicado: (2020)

Systematic comparison of plasma EBV DNA, anti‐EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma
por: Tan, Lu Ping, et al.
Publicado: (2019)

Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma
por: Yuan, Xiaofei, et al.
Publicado: (2023)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma
por: Cui, Linchong, et al.
Publicado: (2023)

Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer
por: Nilsson, Johan S., et al.
Publicado: (2019)

Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma
por: Xu, Xia, et al.
Publicado: (2018)

EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma
por: Ding, Tengteng, et al.
Publicado: (2023)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Gemcitabine and cisplatin regimen facilitates prognosis of advanced nasopharyngeal carcinoma
por: Li, Qiongxuan, et al.
Publicado: (2018)

Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
por: Chen, Peng, et al.
Publicado: (2020)

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
por: Wang, Hong-Bo, et al.
Publicado: (2015)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Role of serum EBV‐VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population
por: Wang, Zeyang, et al.
Publicado: (2018)

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
por: Li, Jiang, et al.
Publicado: (2007)

Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis
por: Lai, Lin, et al.
Publicado: (2021)

Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large‐population retrospective analysis
por: Qu, Weiling, et al.
Publicado: (2020)

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection
por: Guo, Can, et al.
Publicado: (2006)

An inflammatory biomarker‐based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study
por: Li, Xiao‐Hui, et al.
Publicado: (2016)

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
por: Montgomery, Nathan D., et al.
Publicado: (2019)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Effects of hepatitis B virus infection and antiviral therapy on the clinical prognosis of nasopharyngeal carcinoma
por: Weng, Jing‐Jin, et al.
Publicado: (2019)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Changes in plasma EBV-DNA and immune status in patients with nasopharyngeal carcinoma after treatment with intensity-modulated radiotherapy
por: Chen, Qi, et al.
Publicado: (2019)

MiR-30e-5p inhibits the migration and invasion of nasopharyngeal carcinoma via regulating the expression of MTA1
por: Hu, Weiqun, et al.
Publicado: (2020)

Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
por: Yu, Justin, et al.
Publicado: (2021)

Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA
por: Wang, Wen-Yi, et al.
Publicado: (2016)

Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy
por: Ruan, Yanyun, et al.
Publicado: (2019)

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
por: Ferrari, Daris, et al.
Publicado: (2012)

Mechanisms of Epstein‐Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma
por: Wang, Jie, et al.
Publicado: (2020)

Identification of a 7‐microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection
por: Zhang, Huo, et al.
Publicado: (2019)

EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
por: Huo, Shaofen, et al.
Publicado: (2020)

Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma
por: Dochi, Hirotomo, et al.
Publicado: (2022)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
por: Cao, Ya
Publicado: (2017)

The human ATF1 rs11169571 polymorphism associated with risk of nasopharyngeal carcinoma in Southern Chinese populations
por: Peng, Shutang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k188nbded9lnd6dbu57g4uc7c8